Health
Researchers use genetics to identify potential drugs for early management of COVID-19 – News-Medical.net
A new study using human genetics suggests researchers should prioritize clinical trials of drugs that target two proteins to manage COVID-19 in its early stages….
A new study using human genetics suggests researchers should prioritize clinical trials of drugs that target two proteins to manage COVID-19 in its early stages.
The findings appeared online in the journal Nature Medicine in March 2021.
Based on their analyses, the researchers are calling for prioritizing clinical trials of drugs targeting the proteins IFNAR2 and ACE2. The goal is to identify existing drugs, either FDA-approved or in clinical development for other conditions, that can be repurposed…
-
General13 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News16 hours agoSearch for man who ‘faked death’ slowed by unusual French law
-
Business18 hours ago2 ASX 200 large-cap shares that this fundie is cashing in after phenomenal growth
-
Noosa News18 hours agoAustralia’s biggest sheep drive, and the young drover history forgot